The cluster is routine in size and pattern — all sales follow option exercises and are typical for C-suite insiders monetizing vested equity. No bearish signal here given the proportionality check. Monitor for any open-market purchases by insiders, which would be a stronger signal. The stock's strong historical momentum (avg +21.8% at T+20 across prior reports) suggests the market is focused on pipeline catalysts, not insider selling patterns.
Price Chart
Executive Summary
Three C-suite insiders at Nurix Therapeutics (NRIX) sold a total of $534K in open-market shares over a 7-day window, with the Chief Legal Officer accounting for $382K of that total. The sales follow option exercises and are likely liquidity-driven, but the cluster of selling by the CSO, CFO, and CLO at prices near $23-25 per share warrants attention given the stock's recent run-up and the company's $2.6B market cap. The total value is only ~0.02% of market cap, making this a routine, non-material cluster by proportionality standards.
Key Financial Metrics
Key Facts
- Three C-suite insiders sold shares: CSO Gwenn Hansen ($109K), CLO Christine Ring ($382K), and CFO Hans van Houte ($183K)
- Total open-market sales of $534K represent ~0.02% of NRIX's $2.6B market cap
- All sales followed option exercises at $0 or $1.86-$8.72 strike prices, consistent with tax-covering or liquidity-driven selling
- No insider open-market purchases were reported in the cluster window
- The stock has rallied significantly — prior reports on NRIX show strong positive momentum with 88% win rate at T+20
Financial Impact
Total insider sales of $534K, immaterial relative to $2.6B market cap
Risk Factors
- Insider selling could accelerate if the stock continues to rally, creating overhang
- No insider buying to signal conviction at current levels
- The cluster includes the CLO selling the most — legal officers often sell for diversification, not informational reasons
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NRIX-1785971197297 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 29d ago | Insider Cluster | $25.32 $25.10 | ▼ −0.87% | ▲ +0.28% | $22.85 (−9.76%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.22 $27.19 | ▲ +7.81% | ▲ +6.60% | $22.85 (−9.40%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.85 (−9.04%) |
Aug 5, 2026 8w ago | Insider Cluster | $25.12 $26.63 | ▲ +6.01% | ▲ +5.66% | $22.85 (−9.04%) |
Aug 3, 2026 8w ago | Insider Cluster | $24.69 $25.96 | ▲ +5.14% | ▲ +5.24% | $22.85 (−7.45%) |
Jul 30, 2026 9w ago | Insider Cluster | $23.21 $25.53 | ▲ +10.00% | ▲ +6.48% | $22.85 (−1.55%) |
Jul 9, 2026 12w ago | Press Release | $23.06 $23.07 | ▲ +0.04% | ▲ +0.60% | $22.85 (−0.91%) |
Jul 2, 2026 13w ago | Insider Cluster | $23.97 $24.69 | ▲ +3.00% | ▲ +2.07% | $22.85 (−4.67%) |
Jun 11, 2026 16w ago | Institutional Cluster | $16.98 $17.12 | ▲ +0.82% | ▲ +0.39% | $22.85 (+34.57%) |
Jun 8, 2026 16w ago | 8-K | $15.64 $17.04 | ▲ +8.95% | ▲ +6.84% | $22.85 (+46.10%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access